Genus (LSE:GNS) 3-Year EBITDA Growth Rate

: 3.00% (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

Genus's EBITDA per Share for the six months ended in Dec. 2023 was £0.74.

During the past 12 months, Genus's average EBITDA Per Share Growth Rate was 12.00% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 3.00% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 22.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 4.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Genus was 35.30% per year. The lowest was -21.70% per year. And the median was 8.80% per year.

Competitive Comparison

For the Biotechnology subindustry, Genus's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genus 3-Year EBITDA Growth Rate Distribution

For the Biotechnology industry and Healthcare sector, Genus's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Genus's 3-Year EBITDA Growth Rate falls into.

Genus 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Genus (LSE:GNS) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Genus 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Genus's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Genus (LSE:GNS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genus PLC (LSE:GNS) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

GENSF:USA GNSl:UK GBE:Germany

Address

Matrix House, Basing View, Basingstoke, Hants, GBR, RG21 4DZ

Website

https://www.genusplc.com

Genus PLC is a biotechnology company that develops animal genetics for agricultural purposes. The company breeds and distributes the genes of pigs and bulls, scientifically selecting livestock whose offspring are designed to increase the profitability of its customers. In the porcine market, Genus sells boars and sows that produce offspring with desirable characteristics, such as feed-efficient growth or leaner meat. In the dairy and beef markets, the company's primary product is bull semen, which is delivered through artificial insemination to improve its customers' herds and their efficiency. Genus also offers embryos through its subsidiary IVB.